• to lower the chance of significant cardiovascular (coronary heart and blood vessel) complications in adults with kind 2 diabetes and cardiovascular diseaseIn October 2024, Novo Nordisk released a review on scientific journal Nature a couple of novel glucose-delicate insulin NNC2215 which can decrease the potential risk of hypoglycemia in animal… Read More